Ganogen Research Institute
The Ganogen Research Institute is a not-for-profit research organization dedicated to ending the shortage of donor organs. Scientists at the institute have shown that human fetal kidneys and hearts can be transplanted into immunocompromised animals where they subsequently function and grow larger.[1][2] This research has caused the Ganogen Research Institute to be subpoenaed by the United States Congress as part of the larger investigation into the Planned Parenthood 2015 undercover videos controversy.[3][4][5][6] Eugene Gu, Ganogen's founder and CEO, wrote that the subpoena has endangered researchers' lives.[7] [8] [9]
References
- ↑ Chang, N. K.; Gu, J.; Gu, S.; Osorio, R. W.; Concepcion, W.; Gu, E. (1 June 2015). "Arterial Flow Regulator Enables Transplantation and Growth of Human Fetal Kidneys in Rats". 15 (6): 1692–1700. doi:10.1111/ajt.13149 – via Wiley Online Library.
- ↑ "Growing human kidneys in rats sparks ethical debate".
- ↑ "House Panel Issues Subpoenas in Fetal Tissue Research Inquiry". The New York Times. 31 March 2016.
- ↑ "Higher-ed associations join to protest House fetal tissue subpoenas".
- ↑ Redden, Molly (1 April 2016). "Vital fetal tissue research threatened by House of Representatives subpoenas" – via The Guardian.
- ↑ "Scientist pushes fetal tissue research despite political pressure". 31 March 2016.
- ↑ Gu, Eugene; Dyer, Cate (7 July 2016). "Fetal tissue: US panel risks infant and researcher lives". Nature. 535 (7610): 37–37. doi:10.1038/535037c – via www.nature.com.
- ↑ "Science AMA Series: I am Dr. Eugene Gu, President and CEO of Ganogen. I have been subpoenaed by Congress for my research involving fetal tissue but will continue to press on. AMA! • /r/science".
- ↑ "Science Ama Series: I am Eugene Gu, CEO of Ganogen, Inc. I successfully transplanted human fetal kidneys and hearts into animals, which subsequently grew larger and matured. My hope is to end the shortage of donor organs. AMA! • /r/science".
This article is issued from Wikipedia - version of the 11/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.